Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 214

1.

Diagnostic evaluation of separately acquired PET and CT images by nuclear medicine physicians and radiologists in cancer patients.

Quarles van Ufford HM, Quekel LG, van Waes PF, de Haas PJ, de Klerk JM.

Hell J Nucl Med. 2007 May-Aug;10(2):105-8.

PMID:
17684586
[PubMed - indexed for MEDLINE]
2.

Side-by-side reading of PET and CT scans in oncology: which patients might profit from integrated PET/CT?

Reinartz P, Wieres FJ, Schneider W, Schur A, Buell U.

Eur J Nucl Med Mol Imaging. 2004 Nov;31(11):1456-61. Epub 2004 Jul 10.

PMID:
15248033
[PubMed - indexed for MEDLINE]
3.

[Combined FDG PET/CT imaging for restaging of colorectal cancer patients: impact of image fusion on staging accuracy].

Strunk H, Bucerius J, Jaeger U, Joe A, Flacke S, Reinhardt M, Hortling N, Palmedo H.

Rofo. 2005 Sep;177(9):1235-41. German.

PMID:
16123869
[PubMed - indexed for MEDLINE]
4.

[F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.

Jadvar H, Henderson RW, Conti PS.

J Comput Assist Tomogr. 2007 Mar-Apr;31(2):223-8.

PMID:
17414758
[PubMed - indexed for MEDLINE]
5.

Retrospective interactive rigid fusion of (18)F-FDG-PET and CT. Additional diagnostic information in melanoma patients.

Römer W, Nömayr A, Greess H, Fiedler E, Platsch G, Schuler-Thurner B, Pfahlberg A, Hothorn T, Schuler G, Hornegger J, Bautz W, Kuwert T.

Nuklearmedizin. 2006;45(2):88-95.

PMID:
16547570
[PubMed - indexed for MEDLINE]
6.

18FDG-PET in 733 consecutive patients with or without side-by-side CT evaluation: analysis of 921 lesions.

Buell U, Wieres FJ, Schneider W, Reinartz P.

Nuklearmedizin. 2004 Dec;43(6):210-6.

PMID:
15586217
[PubMed - indexed for MEDLINE]
7.

Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?

Casneuf V, Delrue L, Kelles A, Van Damme N, Van Huysse J, Berrevoet F, De Vos M, Duyck P, Peeters M.

Acta Gastroenterol Belg. 2007 Oct-Dec;70(4):331-8.

PMID:
18330088
[PubMed - indexed for MEDLINE]
8.

PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients.

Berthelsen AK, Holm S, Loft A, Klausen TL, Andersen F, Højgaard L.

Eur J Nucl Med Mol Imaging. 2005 Oct;32(10):1167-75. Epub 2005 May 21.

PMID:
15909196
[PubMed - indexed for MEDLINE]
9.
10.

A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.

Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.

Ann Surg. 2009 Dec;250(6):957-63. doi: 10.1097/SLA.0b013e3181b2fafa.

PMID:
19687736
[PubMed - indexed for MEDLINE]
11.

Significant benefit of multimodal imaging: PET/CT compared with PET alone in staging and follow-up of patients with Ewing tumors.

Gerth HU, Juergens KU, Dirksen U, Gerss J, Schober O, Franzius C.

J Nucl Med. 2007 Dec;48(12):1932-9. Epub 2007 Nov 15.

PMID:
18006618
[PubMed - indexed for MEDLINE]
Free Article
12.

The benefit of functional-anatomical imaging with [18F]fluorodeoxyglucose utilizing a dual-head coincidence gamma camera with an integrated X-ray transmission system in non-small cell lung cancer.

Eschmann SM, Bitzer M, Paulsen F, Friedel G, Besenfelder H, Horger M, Reimold M, Dittmann H, Pfannenberg AC, Bares R.

Nucl Med Commun. 2004 Sep;25(9):909-15.

PMID:
15319596
[PubMed - indexed for MEDLINE]
13.

Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.

Messa C, Ceresoli GL, Rizzo G, Artioli D, Cattaneo M, Castellone P, Gregorc V, Picchio M, Landoni C, Fazio F.

Q J Nucl Med Mol Imaging. 2005 Sep;49(3):259-66.

PMID:
16172572
[PubMed - indexed for MEDLINE]
Free Article
14.

Is hybridic positron emission tomography/computerized tomography the only option? The future of nuclear medicine and molecular imaging.

Grammaticos P, Zerva C, Asteriadis I, Trontzos C, Hatziioannou K.

Hell J Nucl Med. 2007 May-Aug;10(2):74-6.

PMID:
17684579
[PubMed - indexed for MEDLINE]
15.

Software-based fusion of PET and CT images for suspected recurrent lung cancer.

Nakamoto Y, Senda M, Okada T, Sakamoto S, Saga T, Higashi T, Togashi K.

Mol Imaging Biol. 2008 May-Jun;10(3):147-53. doi: 10.1007/s11307-008-0131-x. Epub 2008 Feb 22.

PMID:
18293042
[PubMed - indexed for MEDLINE]
16.

Diagnostic performance of fluorodeoxyglucose positron emission tomography/magnetic resonance imaging fusion images of gynecological malignant tumors: comparison with positron emission tomography/computed tomography.

Nakajo K, Tatsumi M, Inoue A, Isohashi K, Higuchi I, Kato H, Imaizumi M, Enomoto T, Shimosegawa E, Kimura T, Hatazawa J.

Jpn J Radiol. 2010 Feb;28(2):95-100. doi: 10.1007/s11604-009-0387-3. Epub 2010 Feb 26.

PMID:
20182843
[PubMed - indexed for MEDLINE]
17.

Value of integrated PET/CT for lesion localisation in cancer patients: a comparative study.

Pelosi E, Messa C, Sironi S, Picchio M, Landoni C, Bettinardi V, Gianolli L, Del Maschio A, Gilardi MC, Fazio F.

Eur J Nucl Med Mol Imaging. 2004 Jul;31(7):932-9. Epub 2004 Feb 27.

PMID:
14991245
[PubMed - indexed for MEDLINE]
18.

Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET.

Antoch G, Saoudi N, Kuehl H, Dahmen G, Mueller SP, Beyer T, Bockisch A, Debatin JF, Freudenberg LS.

J Clin Oncol. 2004 Nov 1;22(21):4357-68.

PMID:
15514377
[PubMed - indexed for MEDLINE]
Free Article
19.

Combined PET/CT in the follow-up of differentiated thyroid carcinoma: what is the impact of each modality?

Zoller M, Kohlfuerst S, Igerc I, Kresnik E, Gallowitsch HJ, Gomez I, Lind P.

Eur J Nucl Med Mol Imaging. 2007 Apr;34(4):487-95. Epub 2006 Nov 14.

PMID:
17103166
[PubMed - indexed for MEDLINE]
20.

Granulomatous disease: is it a nuisance or an asset during PET/computed tomography evaluation of lung cancers?

Chundru S, Wong CY, Wu D, Balon H, Palka J, Chang CY, Gaskill M, Cheng CY, Huang WS, Fink-Bennett D.

Nucl Med Commun. 2008 Jul;29(7):623-7. doi: 10.1097/MNM.0b013e3282fdc979.

PMID:
18528184
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk